Keyword Connections

synuclein

Journals

1

1 neurobiology of aging

Research Groups

0

No Research Group Connected

Bibliographies

35

1 Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology.

2 Differential Gamma-Synuclein Expression in Acute and Chronic Retinal Ganglion Cell Death in the Retina and Optic Nerve.

3 Erectile Dysfunction Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study in Olmsted County

4 The influence of N-terminal acetylation on micelle-induced conformational changes and aggregation of α-Synuclein.

5 High-Density Single-Layer Coating of Gold Nanoparticles onto Multiple Substrates by Using an Intrinsically Disordered Protein of α-Synuclein for Nanoapplications.

6 Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein.

7 Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model.

8 Dysautonomia in the synucleinopathies: not just orthostatic hypotension

9 Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in α-synucleinopathies

10 Autonomic Dysfunction in α-Synucleinopathies

11 Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.

12 Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.

13 Pick's disease: α- and β-synuclein-immunoreactive Pick bodies in the dentate gyrus

14 Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD

15 5-ht2a receptor binding in the frontal cortex of parkinson’s disease patients and alpha-synuclein overexpressing mice: a postmortem study

16 rotenone upregulates alpha-synuclein and myocyte enhancer factor 2d independently from lysosomal degradation inhibition

17 dj-1 inhibits α-synuclein aggregation by regulating chaperone-mediated autophagy

18 lrrk2 antisense oligonucleotides ameliorate α-synuclein inclusion formation in a parkinson’s disease mouse model

19 Αlpha-synuclein as a mediator in the interplay between aging and parkinson’s disease

20 a novel microfluidic cell co-culture platform for the study of the molecular mechanisms of parkinson’s disease and other synucleinopathies

21 glucocerebrosidase mutations and synucleinopathies. potential role of sterylglucosides and relevance of studying both gba1 and gba2 genes

22 alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection

23 effects of optimized hα-synuclein dna vaccine on cyclooxygenase-2 expression in substantia nigra in a murine model of parkinson’s disease

24 the impact of paeoniflorin on α-synuclein degradation pathway

25 a rapid, semi-quantitative assay to screen for modulators of alpha-synuclein oligomerization ex vivo

26 advancing stem cell models of alpha-synuclein gene regulation in neurodegenerative disease

27 modulation of alpha-synuclein expression and associated effects by microrna let-7 in transgenic c. elegans

28 the contribution of α-synuclein spreading to parkinson’s disease synaptopathy

29 normalization of overexpressed α-synuclein causing parkinson's disease by a moderate gene silencing with rna interference

30 α-synuclein alters toll-like receptor expression

31 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model

32 Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies

33 Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease

34 Measurement of CSF α‐synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer’s disease

35 Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies